Allan Jarvis
Board Member
Allan Jarvis was previously SVP of Corporate Development at Sanofi Pasteur, the Vaccine Division of Sanofi. He served in that position for 8 years and during that time was responsible for managing the company’s growth through alliances, joint-ventures, partnerships, mergers, acquisitions, and the licensing of products and technology. Prior to that, he was Vice President, Business Development and Strategy for the Vaccine Business Unit of Wyeth Pharmaceuticals, now Pfizer Vaccines.
Allan received his PhD in Molecular Genetics from the University of California and held NIH Post-Doctoral Fellowships from 1976-1980 at Sloan Kettering Cancer Institute and the Worcester Foundation for Experimental Biology. In 1980, he co-founded Damon Biotech, Inc. where he held diverse positions of increasing responsibility from Manager, Molecular Biology to Vice President, Research and Vice President Business Development. From 1990 to 1992, he worked at Abbott Laboratories, Inc., as Director, Business Development. In 1992 he joined Repligen Corp. in the dual role of Vice President, Business Planning for the parent company and Sr. Vice President, Commercial Development for its wholly owned subsidiary, Amira, Inc. His primary areas of business focus include: partnering, negotiations, valuing products and technologies, strategic planning and alliance management.